Basic determinants of myocardial hypertrophy: a review of molecular mechanisms

G Cooper1

  • 1Department of Medicine, Medical University of South Carolina, Charleston 29425, USA.

Insights

Cardiac hypertrophy, an increase in heart muscle mass, can fail to compensate for increased hemodynamic load. This leads to heart failure due to abnormal contractile performance, emphasizing the need to view cardiac hypertrophy as a growth process.

Area of Science:

  • Cardiology
  • Physiology
  • Molecular Biology

Background:

  • The heart's primary response to increased hemodynamic load is cardiac hypertrophy.
  • Compensated cardiac hypertrophy can maintain organ-level function despite increased workload.

Purpose of the Study:

  • To understand the mechanisms underlying the failure of cardiac hypertrophy to prevent congestive heart failure.
  • To identify cardiac hypertrophy as a growth process critical for developing interventions.

Main Methods:

  • The study reviews existing literature on cardiac hypertrophy and hemodynamic load.
  • It analyzes the phenotypic changes in myocardium during hypertrophy.
  • It correlates these changes with contractile performance and heart failure outcomes.

Main Results:

  • Cardiac hypertrophy can be abrogated by progressive contractile dysfunction per unit of myocardium.
  • Phenotypic changes during hypertrophy are dependent on the type of hemodynamic load.
  • These changes lead to imperfect compensation and eventual congestive heart failure.

Conclusions:

  • Cardiac hypertrophy must be understood as a growth process to develop early interventions.
  • Preventing congestive heart failure requires addressing the specific phenotypic changes in hypertrophied myocardium.
  • Understanding the load-dependent nature of these changes is crucial for therapeutic strategies.

Related Concept Videos

Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cellular Adaptation II: Hypertrophy01:26

Cellular Adaptation II: Hypertrophy

Hypertrophy is the increase in the size of individual cells, resulting in the enlargement of a tissue or organ. Unlike hyperplasia, which involves an increase in cell number, hypertrophy is characterized by an increase in cell volume. This process often occurs in response to higher functional demand or hormonal stimulation, leading to the production of more structural proteins and organelles, thereby enhancing the cells' work capacity.There are two primary types of hypertrophy: physiological...